Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet… Eikon Therapeutics (NAS: EIKN) is based in Millbrae, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). It has raised $1.5 billion.
Last price · $/share
—
Implied valuation
$971.7M
Total raised
$1.5B
Last round
—
Team — not yet on record
No current team members for Eikon Therapeutics (NAS: EIKN) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Eikon Therapeutics (NAS: EIKN) with a free account
·The complete investor list: 22 names
·Watch Eikon Therapeutics (NAS: EIKN): the Monday email on marks, rounds and moves
